Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The objective of CISCO is therefore to identify prognostic biomarkers of MS activity in early-stage patients.
Epistemonikos ID: a89c5f9cb7ffe943a4006f7c93d5224f9c218e96
First added on: May 07, 2024